Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-17
1997-06-03
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514884, 549333, 549347, A01N 4332, C07D32100
Patent
active
056355297
ABSTRACT:
Novel O-substituted or O-unsubstituted 6-sulfonamido-1,3-dioxepane-5-ols having hypoglycemic activity are obtained from 6-amino-1,3-dioxepane-5-ol, tetrahydro-6H-[1,3]-dioxepino[5,6-d]oxazole, 5,6-epoxy-1,3-dioxepane or N-sulfonyl-tetrahydro-1H,4H-[1,3]-dioxepino[5,6-b]azirine as starting materials.
REFERENCES:
Chemical Abstract vol. 83 No. 164098 (1975) "Stereocontrolled route to a key intermediate for the synthesis of maytansine".
Dumic Miljenko
Filic Darko
Jamnicky Blanka
Vinkovic Mladen
Covington Raymond
Ivy C. Warren
PLIVA farmaceutska, kemijska, prehrambena i kozmeticka industrij
LandOfFree
Sulfonamidodioxepanes, methods of preparation, intermediates, sa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamidodioxepanes, methods of preparation, intermediates, sa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamidodioxepanes, methods of preparation, intermediates, sa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-392050